Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022
April 07 2022 - 08:00AM
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a
company pioneering a single-molecule protein analysis platform for
quantifying the proteome, today announced it will report
financial results for the first quarter 2022 before market open on
Tuesday, May 3rd, 2022.
The company’s management will webcast a
corresponding conference call beginning at 5:30 a.m. Pacific Time /
8:30 a.m. Eastern Time to discuss its results, business
developments, and outlook. Live audio of the webcast will be
available on the “Investors” section of the company website at:
www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle and its research and
development headquarters in the San Francisco Bay Area, Nautilus is
a development stage life sciences company creating a platform
technology for quantifying and unlocking the complexity of the
proteome. Nautilus’ mission is to transform the field of proteomics
by democratizing access to the proteome and enabling fundamental
advancements across human health and medicine. To learn more about
Nautilus, visit www.nautilus.bio.
Contacts
Investors:InvestorRelations@nautilus.bio
Media:Thermal for Nautilus BiotechnologyKaustuva
DasPress@nautilus.bio
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Mar 2023 to Mar 2024